Clinical Trial Update: A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the pharmacokinetics, efficacy, safety and tolerability of CABENUVA has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CABENUVA (cabotegravir and rilpivirine)

Snippet

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Conditions: HIV-1-infection, HIV Infections | Phase 3 | Status: COMPLETED